Qualigen Therapeutics Inc (QLGN)
BIOTECHNOLOGY
Last updated: Nov 16, 2026 at 4:00 PM ET
Qualigen Therapeutics Inc (QLGN) Stock Chart
Qualigen Therapeutics (QLGN) closed at $0.63 on Nov 16, 2026. Its price fell 75.1% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 71.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $427,500.00 in Jan 2017 and its lowest $0.66 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart QLGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for QLGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 52.3%, and over 6 months it fell 48.8%. The month-end price fell 97.4% over the 3 years through Oct 2026, a compound annual decline of 70.4%.
| Period | Change |
|---|---|
| 1 month | -45.7% |
| 3 months | -52.3% |
| 6 months | -48.8% |
| 12 months | -75.1% |
| 12 months, with dividends | -75.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -97.4% | -70.4% |
| 5 years | -99.8% | -71.9% |
| 10 years | -100.0% | -71.6% |
Price by Year
Its best calendar year was 2020, when the price fell 28.8%, and its weakest was 2022, when it fell 88.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.01 | -56.8% |
| 2025 | $2.34 | -44.4% |
| 2024 | $4.21 | -84.7% |
| 2023 | $27.50 | -57.3% |
| 2022 | $64.45 | -88.0% |
| 2021 | $535.00 | -64.5% |
| 2020 | $1,505.00 | -28.8% |
| 2019 | $2,112.50 | -71.8% |
| 2018 | $7,500.00 | -81.8% |
| 2017 | $41,125.00 | -87.9% |
Trading Range
The price is 44.3% below its 50-day average of $1.13 and 45.6% below its 200-day average of $1.16.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.63 | |
| 50-day average | $1.13 | -44.3% |
| 200-day average | $1.16 | -45.6% |
Price Risk
Over 3 years, its largest fall from a peak was 98.3%.
| Measure | Value |
|---|---|
| 1-year beta | 2.76 |
| Largest fall, 1 year | -80.4% |
| Largest fall, 3 years | -98.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About QLGN
What is QLGN's 1-year price change?
Qualigen Therapeutics's price fell 75.1% over the past 12 months. With dividends included, the 12-month total return was -75.1%.
What is QLGN's 5-year price change?
Qualigen Therapeutics's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 71.9%. These figures leave out dividends.
What is QLGN's beta?
Qualigen Therapeutics's 1-year beta against the S&P 500 is 2.76, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.4%.
Is the QLGN chart free?
Yes. Advanced Charting for QLGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
QLGN pages: Overview, Charting, Financials